🇺🇸 FDA

Drug profile · INN

cantharidin

YCANTH

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

cantharidin (YCANTH) is an FDA-listed pharmaceutical active ingredient. Associated with Verrica Pharmaceuticals. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN cantharidin
Brand YCANTH
Route TOPICAL
Formulation SOLUTION
Originator Verrica Pharmaceuticals

Related patents

Search patents →

  1. US 12221452

    Synthesis of cantharidin

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11168091

    Quantification and preparation of pharmaceutical grade cantharidin

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10745413

    Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cantharidin?

cantharidin (YCANTH) is an FDA-listed pharmaceutical active ingredient. Associated with Verrica Pharmaceuticals. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for cantharidin?

YCANTH is a marketed brand name for cantharidin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cantharidin?

cantharidin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.